AFRICA ( Commonwealth Union) _ Prior to World Malaria Day on April 25, a global health executive claimed that extreme weather conditions in Malawi have contributed to very sharp increases in malaria cases and fatalities.
Peter Sands reiterated that ahead of the Global Fund to Fight AIDS, Tuberculosis, and Malaria, Cyclone Freddy in March caused six months’ worth of rainfall in six days, which caused cases there to increase as well. He said the sharp rise in instances brought on by weather disasters linked to climate change demonstrated the need to get ahead of this right away.
In both countries, stagnant water from receding waters created the ideal breeding grounds for mosquitoes that spread malaria. The WHO estimates that malaria will cause 247 million infections and 619,000 fatalities globally in 2021. The RTS, S immunization was given to over a million children in Ghana, Kenya, and Malawi last year as a result of scientific developments made by the British pharmaceutical giant GSK.
This month, Ghana became the first country in the world to receive regulatory clearance for the use of another vaccine, R21/Matrix-M, created by Britain’s Oxford University. Due to the relative cost of immunization and the difficulty of large-scale deployment, vaccines had less potential to combat the disease than standard diagnosis and treatment infrastructure.
The most vulnerable groups to malaria are children under five and expectant women, and mortality in both groups is primarily due to delayed diagnosis and treatment. In both countries, stagnant water from receding waters created the ideal breeding grounds for mosquitoes that spread malaria. Despite the fact that there have been some advancements in the fight against malaria, Sands emphasized that a child still perishes from the illness every minute.
However, the WHO highlighted that malaria caused a projected 247 million cases worldwide in 2021 and 619,000 fatalities. More than a million kids in Ghana, Kenya, and Malawi received the RTS, S vaccination last year thanks to scientific advancements made by the British pharmaceutical behemoth GSK. This month, Ghana became the first country in the world to receive regulatory clearance for the use of another vaccine, R21/Matrix-M, created by Britain’s Oxford University.
